Department of Ophthalmology

Peer-Reviewed Publications 2009-2014

Sharif NA, McLaughlin MA, Kelly CR, Katoli P, Drace C, Husain S, Crosson C, Toris C, Zhan GL, and Camras C. Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the cynomolgus monkey eyes. Exp Eye Res. 88:386-397, 2009, PMID: 18992242.

Webb JG, Yang X, Crosson CE. Expression of the kallikrein/kinin system in human anterior segment. Exp Eye Res 89:126-132, 2009, PMID: 19268469, PMCID: PMC2713788.

Husain S, Potter DE, and Crosson CE. Opioid receptor-activation: Retina protected from ischemic injury. Invest Ophthalmol Vis Sci. 50:3853-3859, 2009, PMID: 19324855.

Ablonczy Z, Prakasam A, Fant J, Fauq A, Crosson CE, and Sambamurti K. Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through γ-secretase. J Biol Chem 284:30177-30186, 2009, PMID: 19723623, PMCID: PMC2781573.

Harrison BA, Whitlock, NA, Voronkov MV, Almstead ZY, Gu KJ, Mabon R, Gardyan M, Hamman BD, Allen J, Gopinathan S, McKnight B, Crist M, Zhang Y, Liu Y, Courtney LF, Key B, Zhou J, Patel N, Yates PW, Liu Q, Wilson AG, Kimball SD, Crosson CE, Rice DS, and Rawlins DB. Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma. J Med Chem 52:6515-6518, 2009, PMID: 19831390.

Crosson CE, Mani SK, Husain S, Alsarraf O, and Menick DR. Inhibition of histone deacetylase protects the retina from ischemic injury. Invest Ophthalmol Vis Sci 51:3639-3645, 2010, PMID: 20164449, PMCID: PMC2904015.

Husain S, Liou GI, and Crosson CE. Opioid receptor activation: Suppression of ischemia/reperfusion-induced production of TNF-α in the retina. Invest Ophthalmol Vis Sci 52:2577-2583, 2011, PMID: 21282567, PMCID: PMC3088550.

Webb JG, Yang X, and Crosson CE. Bradykinin activation of extracellular signal-regulated kinases in human trabecular meshwork cells. Exp Eye Res 92:495-501, 2011, PMID: 21426904, PMCID: PMC3104070.

Trivedi RH, Nutaitis M, Vroman D, and Crosson CE. Influence of race and age on aqueous humor levels of transforming growth factor-beta 2 in glaucomatous and nonglaucomatous eyes. J Ocul Pharmacol Ther 27:477-480, 2011, PMID: 21034224, PMCID: PMC3197083.

Ablonczy Z, Liu Y, Dahrouj M, Tang PH, Sambamurti K, Marmorstein AD, and Crosson CE. Human retinal pigment epithelium cells as functional models for the RPE in vivo. Invest Ophthalmol Vis Sci 52:8614-8620, 2011, PMID: 21960553.

Dahrouj M, Alsarraf O, Liu Y, Crosson CE, Ablonczy Z. (2013). C-type natriuretic peptide protects the retinal pigment epithelium against advanced glycation end product-induced barrier dysfunction. Journal of Pharmacology & Experimental Therapeutics, 344(1):96-102. PMCID: PMC353404

Liu B, Staron M, Hong F, Wu X, Sun S, Morales C, Crosson CE, Kim I, Wu I, Li Z. (2013). Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway. Proceedings of the National Academy of Sciences of the USA, 110(17):6877-6882. PMCID: PMC3637754

Fan J, Alsarraf O, Dahrouj M, Platt KA, Chou CJ, Rice DS, Crosson CE. (2013). Inhibition of HDAC2 protects the retina from ischemic injury. Investigative Ophthalmology and Visual Science, 54(6):4072-4080. PMCID: PMC3681476

Rogers ME, Navarro ID, Perkumas KM, Niere SM, Allingham RR, Crosson CE, Stamer WD. (2013). Pigment epithelium-derived factor decreases outflow facility. Investigative Ophthalmology and Visual Science, 54(10):6655-6661. PMCID: PMC3796938

Top of Page


© Medical University of South Carolina | 171 Ashley Avenue, Charleston, SC 29425